UBS Group AG - ONCONOVA THERAPEUTICS INC ownership

ONCONOVA THERAPEUTICS INC's ticker is ONTXW and the CUSIP is 68232V116. A total of 3 filers reported holding ONCONOVA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ONCONOVA THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$2,000
-81.8%
13,171
-63.7%
0.00%
Q1 2021$11,000
+266.7%
36,284
+46.0%
0.00%
Q4 2020$3,00024,857
+556.9%
0.00%
Q3 2020$03,7840.0%0.00%
Q2 2020$03,7840.0%0.00%
Q1 2020$0
-100.0%
3,784
-89.6%
0.00%
Q4 2019$1,00036,416
+862.4%
0.00%
Q3 2019$0
-100.0%
3,7840.0%0.00%
Q2 2019$1,0003,7840.0%0.00%
Q1 2019$03,784
+5.3%
0.00%
Q4 2018$03,5920.0%0.00%
Q3 2018$03,592
-23.8%
0.00%
Q2 2018$0
-100.0%
4,717
+31.3%
0.00%
Q1 2018$1,0003,592
+506.8%
0.00%
Q4 2017$0
-100.0%
592
-60.3%
0.00%
Q2 2017$1,0000.0%1,4910.0%0.00%
Q1 2017$1,0001,4910.00%
Other shareholders
ONCONOVA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
UBS Group AG 24,857$3,0000.00%
Citadel Advisors 32,041$3,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 117,348$12,0000.00%
Virtu Financial LLC 34,689$3,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ONCONOVA THERAPEUTICS INC shareholders